High rates of relapse to drug use after prolonged drug-free periods characterize the behavior of experienced heroin and cocaine users, and of people in dietary treatment who attempt to restrict the intake of high-fat palatable food.? ? The behavioral and neurochemical events that contribute to these high rates, however, are not well understood. Relapse can be induced in human subjects and laboratory animals by reexposure to the drug (or food) previously used, reexposure to environmental cues paired with drug (or food) self-administration, and by exposure to environmental stressors. We are using an animal model of relapse, a reinstatement model, to study brain systems and neurotransmitters involved in relapse induced by environmental stressors, conditioned drug (or food) cues and drug (or food) reexposure in rats with a history of heroin, cocaine or palatable high-fat food self-administration. ? ? During the last year, we reported several findings. In a study with rats trained to self-administer palatable food, we found that the stress hormone corticotrophin-releasing factor plays a role in stress-induced relapse to food seeking, while the gut hormone peptide YY(3-36) plays a role in relapse induced by acute exposure to the palatable food or to cues previously associated with the intake of this food. In studies on the neuronal mechanisms of relapse to heroin seeking induced by exposure to the drug-associated environment, we found that glutamate and dopamine transmission in the rat nucleus accumbens are involved in this relapse. In studies on the molecular mechanisms underlying the time-dependent increases in responsiveness to cocaine-associated cues after withdrawal from the drug, we found that glutamate transmission in the central amygdala plays a role in this phenomenon.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000434-07
Application #
7321051
Study Section
(BNRB)
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2006
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Calu, Donna J; Stalnaker, Thomas A; Franz, Theresa M et al. (2007) Withdrawal from cocaine self-administration produces long-lasting deficits in orbitofrontal-dependent reversal learning in rats. Learn Mem 14:325-8
Schoenbaum, Geoffrey; Stalnaker, Thomas A; Shaham, Yavin (2007) A role for BDNF in cocaine reward and relapse. Nat Neurosci 10:935-6
Ghitza, Udi E; Nair, Sunila G; Golden, Sam A et al. (2007) Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model. J Neurosci 27:11522-32
Bossert, Jennifer M; Poles, Gabriela C; Wihbey, Kristina A et al. (2007) Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci 27:12655-63
Marinelli, Peter W; Funk, Douglas; Juzytsch, Walter et al. (2007) The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) 195:345-55
Cooper, Ayelet; Barnea-Ygael, Noam; Levy, Dino et al. (2007) A conflict rat model of cue-induced relapse to cocaine seeking. Psychopharmacology (Berl) 194:117-25
Harvey, Brandon K; Hope, Bruce T; Shaham, Yavin (2007) Tolerance to opiate reward: role of midbrain IRS2-Akt pathway. Nat Neurosci 10:9-10
Lu, Lin; Uejima, Jamie L; Gray, Sarah M et al. (2007) Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving. Biol Psychiatry 61:591-8
Lu, Lin; Koya, Eisuke; Zhai, Haifeng et al. (2006) Role of ERK in cocaine addiction. Trends Neurosci 29:695-703
Shepard, Jack D; Chuang, David T; Shaham, Yavin et al. (2006) Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology (Berl) 185:505-13

Showing the most recent 10 out of 46 publications